Related Experiment Video
Updated: Aug 16, 2026

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016
Antibacterial agents in infections of the central nervous system
1Department of Medicine, Medical College of Pennsylvania, Hahnemann University, School of Medicine, Philadelphia, USA.
Abstract:
Experimental animal models have provided information applicable to antimicrobial therapy of infections of the central nervous system. The efficacy of an antimicrobial agent in the therapy of bacterial meningitis depends on its ability to penetrate the blood-brain barrier, its activity in purulent cerebrospinal fluid, and a demonstration of rapid bactericidal activity against the offending pathogen. The recent emergence of resistant pathogens is challenging the therapy for bacterial meningitis. Various strategies for treating resistant pathogens have been evaluated in experimental animal models. Encouraging results have led to clinical trials to evaluate the efficacy of newer agents, alone or in combination with standard regimens.
Insights
Experimental animal models guide antimicrobial therapy for central nervous system infections, including bacterial meningitis. New strategies are being tested in clinical trials to combat resistant pathogens.
Area of Science:
- * Neuroscience
- * Infectious Diseases
- * Pharmacology
Background:
- * Experimental animal models are crucial for understanding antimicrobial therapy in central nervous system (CNS) infections.
- * Bacterial meningitis treatment efficacy relies on drug penetration of the blood-brain barrier, activity in cerebrospinal fluid (CSF), and rapid bactericidal action.
- * The rise of antimicrobial resistance poses a significant challenge to treating bacterial meningitis.
Purpose of the Study:
- * To review the role of experimental animal models in evaluating antimicrobial therapies for CNS infections.
- * To discuss strategies for overcoming antimicrobial resistance in bacterial meningitis.
- * To highlight the translation of promising preclinical findings into clinical trials.
Main Methods:
- * Review of existing literature on experimental animal models for CNS infections.
- * Analysis of factors influencing antimicrobial efficacy in bacterial meningitis.
- * Examination of novel therapeutic strategies against resistant pathogens.
Main Results:
- * Animal models have yielded valuable insights into antimicrobial drug properties essential for CNS penetration and efficacy.
- * Various treatment strategies targeting resistant bacterial meningitis have shown promise in preclinical studies.
- * Encouraging results from animal models have prompted clinical investigations of new antimicrobial agents.
Conclusions:
- * Experimental animal models remain indispensable for advancing antimicrobial therapy for CNS infections.
- * Addressing antimicrobial resistance in bacterial meningitis requires innovative therapeutic approaches.
- * Clinical trials informed by preclinical research are vital for validating new treatment regimens.
More Related Videos
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bacterial Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction

